{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:19:34Z","timestamp":1784128774824,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23HL161332"],"award-info":[{"award-number":["K23HL161332"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AR070253"],"award-info":[{"award-number":["P30AR070253"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI130109"],"award-info":[{"award-number":["R01AI130109"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI136041"],"award-info":[{"award-number":["R01AI136041"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI143855"],"award-info":[{"award-number":["R01AI143855"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL136209"],"award-info":[{"award-number":["R01HL136209"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37AI052353"],"award-info":[{"award-number":["R37AI052353"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 HG00868"],"award-info":[{"award-number":["U01 HG00868"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI095219"],"award-info":[{"award-number":["U19 AI095219"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jaip.2022.11.001","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T12:23:33Z","timestamp":1667823813000},"page":"492-499.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Patient Characteristics Associated With Reactions to Mrgprx2-Activating Drugs in an Electronic Health Record\u2013Linked Biobank"],"prefix":"10.1016","volume":"11","author":[{"given":"Dinah","family":"Foer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth W.","family":"Karlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.11.001_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaci.2018.01.034","article-title":"Mast cells signal their importance in health and disease","volume":"142","author":"Olivera","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.11.001_bib2","series-title":"Middleton\u2019s allergy principles and practice","author":"Adkinson","year":"2014"},{"key":"10.1016\/j.jaip.2022.11.001_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2022.11.001_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000453265","article-title":"Classification of drug hypersensitivity into allergic, p-i, and pseudo-allergic forms","volume":"171","author":"Pichler","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.11.001_bib5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/all.13301","article-title":"Allergic Fc\u03b5RI- and pseudo-allergic MRGPRX2-triggered mast cell activation routes are independent and inversely regulated by SCF","volume":"73","author":"Babina","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.11.001_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29965-8","article-title":"MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia","volume":"8","author":"Navin\u00e9s-Ferrer","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2022.11.001_bib7","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3389\/fimmu.2018.03027","article-title":"Mas-related G protein-coupled receptor-X2 (MRGPRX2) in drug hypersensitivity reactions","volume":"9","author":"Porebski","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2022.11.001_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav0216","article-title":"MRGPR-mediated activation of local mast cells clears cutaneous bacterial infection and protects against reinfection","volume":"5","author":"Arifuzzaman","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.jaip.2022.11.001_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2019.103923","article-title":"Gold induces a pseudo-allergic reaction via MRGPRX2 both in\u00a0vitro and in\u00a0vivo","volume":"341","author":"Zeng","year":"2019","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaip.2022.11.001_bib10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cbi.2019.05.014","article-title":"Polymyxin B and polymyxin E induce anaphylactoid response through mediation of Mas-related G protein-coupled receptor X2","volume":"308","author":"Zhan","year":"2019","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jaip.2022.11.001_bib11","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/eji.201746951","article-title":"Typical antimicrobials induce mast cell degranulation and anaphylactoid reactions via MRGPRX2 and its murine homologue MRGPRB2","volume":"47","author":"Zhang","year":"2017","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2022.11.001_bib12","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.jaip.2019.02.015","article-title":"Mastocytosis, quinolones, MRGPRX2, and anaphylaxis","volume":"7","author":"Weiler","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.11.001_bib13","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3390\/ijms18061223","article-title":"Reclassifying anaphylaxis to neuromuscular blocking agents based on the presumed patho-mechanism: IgE-mediated, pharmacological adverse reaction or \u201cinnate hypersensitivity\u201d","volume":"18","author":"Spoerl","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2022.11.001_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaci.2021.03.049","article-title":"Multifaceted MRGPRX2: new insight into the role of mast cells in health and disease","volume":"148","author":"Roy","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.11.001_bib15","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jaip.2019.01.059","article-title":"Anaphylaxis to quinolones in mastocytosis: hypothesis on the mechanism","volume":"7","author":"Giavina-Bianchi","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.11.001_bib16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2014.05.004","article-title":"Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria","volume":"134","author":"Fujisawa","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.11.001_bib17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jid.2020.06.030","article-title":"MRGPRX2 activation causes increased skin reactivity in patients with chronic spontaneous urticaria","volume":"141","author":"Shtessel","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2022.11.001_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-017-0698-3","article-title":"Upregulation of Mas-related G protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1","volume":"19","author":"Manorak","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2022.11.001_bib19","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.immuni.2019.03.013","article-title":"Activation of mast-cell-expressed Mas-related G-protein-coupled receptors drives non-histaminergic itch","volume":"50","author":"Meixiong","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2022.11.001_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaip.2018.06.010","article-title":"Drug-induced anaphylaxis documented in electronic health records","volume":"7","author":"Dhopeshwarkar","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.11.001_bib21","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.jaip.2019.05.027","article-title":"Frequency of clonal mast cell diseases among patients presenting with anaphylaxis: a prospective study in 178 patients from 5 tertiary centers in Spain","volume":"7","author":"Gonz\u00e1lez-de-Olano","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.11.001_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.anai.2011.11.006","article-title":"Multiple drug intolerance syndrome: prevalence, clinical characteristics, and management","volume":"108","author":"Macy","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"Suppl","key":"10.1016\/j.jaip.2022.11.001_bib23","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs","volume":"8","author":"Broyles","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.11.001_bib24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.anai.2020.04.017","article-title":"Rapid desensitization to antineoplastic drugs in an outpatient immunoallergology clinic: outcomes and risk factors","volume":"125","author":"Caiado","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.11.001_bib25","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jaip.2018.11.023","article-title":"Drug hypersensitivity reactions documented in electronic health records within a large health system","volume":"7","author":"Wong","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.11.001_bib26","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jaip.2020.09.010","article-title":"Safety, efficacy, and effectiveness of delabeling in patients with multiple drug allergy labels","volume":"9","author":"Vethody","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.11.001_bib27","first-page":"11","article-title":"The Biobank portal for partners personalized medicine: a query tool for working with consented Biobank samples, genotypes, and phenotypes using i2b2","volume":"6","author":"Gainer","year":"2016","journal-title":"J\u00a0Pers Med"},{"key":"10.1016\/j.jaip.2022.11.001_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12916-021-02198-9","article-title":"Interaction of obesity polygenic score with lifestyle risk factors in an electronic health record Biobank","volume":"20","author":"Dashti","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.jaip.2022.11.001_bib29","doi-asserted-by":"crossref","first-page":"zsaa189","DOI":"10.1093\/sleep\/zsaa189","article-title":"Sleep health, diseases, and pain syndromes: findings from an electronic health record Biobank","volume":"44","author":"Dashti","year":"2021","journal-title":"Sleep"},{"key":"10.1016\/j.jaip.2022.11.001_bib30","first-page":"2","article-title":"Building the partners healthcare Biobank at partners personalized medicine: informed consent, return of research results, recruitment lessons and operational considerations","volume":"6","author":"Karlson","year":"2016","journal-title":"J\u00a0Pers Med"},{"key":"10.1016\/j.jaip.2022.11.001_bib31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/jamia\/ocx139","article-title":"A\u00a0value set for documenting adverse reactions in electronic health records","volume":"25","author":"Goss","year":"2018","journal-title":"J\u00a0Am Med Inform Assoc"},{"key":"10.1016\/j.jaip.2022.11.001_bib32","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaip.2020.10.048","article-title":"How to assess effectiveness of biologics for asthma and what steps to take when there is not benefit","volume":"9","author":"Pepper","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.11.001_bib33","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jaci.2021.04.013","article-title":"Prevalence of mastocytosis and Hymenoptera venom allergy in the United States","volume":"148","author":"Schuler","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.11.001_bib34","first-page":"40","article-title":"Drug-induced anaphylaxis survey in Portuguese Allergy Departments","volume":"24","author":"Faria","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2022.11.001_bib35","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/all.12168","article-title":"Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010","volume":"68","author":"Renaudin","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.11.001_bib36","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaip.2020.09.021","article-title":"Emerging causes of drug-induced anaphylaxis: a review of anaphylaxis-associated reports in the FDA Adverse Event Reporting System (FAERS)","volume":"9","author":"Yu","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.11.001_bib37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.anai.2021.10.004","article-title":"Low risk of contrast media-induced hypersensitivity reactions in all subtypes of systemic mastocytosis","volume":"128","author":"Schwaab","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.11.001_bib38","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.jaip.2020.05.057","article-title":"Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression","volume":"8","author":"Robey","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.11.001_bib39","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaci.2021.06.017","article-title":"Hereditary alpha tryptasemia is not associated with specific clinical phenotypes","volume":"149","author":"Chollet","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.11.001_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jaip.2018.07.022","article-title":"Identification of inpatient allergic drug reactions using ICD-9-CM codes","volume":"7","author":"Saff","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.11.001_bib41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.anai.2019.11.026","article-title":"Capturing anaphylaxis through medical records: are ICD and CPT codes sufficient?","volume":"124","author":"Tuttle","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.11.001_bib42","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/jpc.13483","article-title":"Inaccurate diagnosis of paediatric anaphylaxis in three Australian Emergency Departments","volume":"53","author":"Thomson","year":"2017","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.jaip.2022.11.001_bib43","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.jaci.2020.12.626","article-title":"Tick peptides evoke itch by activating MrgprC11\/MRGPRX1 to sensitize TRPV1 in pruriceptors","volume":"147","author":"Li","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl","key":"10.1016\/j.jaip.2022.11.001_bib44","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jaci.2019.02.004","article-title":"Regulation of the pleiotropic effects of tissue-resident mast cells","volume":"144","author":"Huber","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.11.001_bib45","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1053\/j.gastro.2020.12.076","article-title":"Inflamed ulcerative colitis regions associated with MRGPRX2-mediated mast cell degranulation and cell activation modules, defining a new therapeutic target","volume":"160","author":"Chen","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.11.001_bib46","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/PTS.0000000000000711","article-title":"Improving allergy documentation: a retrospective electronic health record system-wide patient safety initiative","volume":"18","author":"Li","year":"2022","journal-title":"J\u00a0Patient Saf"},{"key":"10.1016\/j.jaip.2022.11.001_bib47","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2019.11.027","article-title":"Global trends in anaphylaxis epidemiology and clinical implications","volume":"8","author":"Turner","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.11.001_bib48","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jamia\/ocx071","article-title":"Biases introduced by filtering electronic health records for patients with \u201ccomplete data","volume":"24","author":"Weber","year":"2017","journal-title":"J\u00a0Am Med Inform Assoc"},{"key":"10.1016\/j.jaip.2022.11.001_bib49","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/bjd.17608","article-title":"Under-representation of skin of colour in dermatology images: not just an educational issue","volume":"180","author":"Lester","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.11.001_bib51","author":"UK Biobank"},{"key":"10.1016\/j.jaip.2022.11.001_bib52","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4049\/jimmunol.1701793","article-title":"Naturally occurring missense MRGPRX2 variants display loss of function phenotype for mast cell degranulation in response to substance P, hemokinin-1, human beta-defensin-3, and icatibant","volume":"201","author":"Alkanfari","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2022.11.001_bib53","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/cells10010156","article-title":"MRGPRX2 activation by rocuronium: insights from studies with human skin mast cells and missense variants","volume":"10","author":"Chompunud Na Ayudhya","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaip.2022.11.001_bib54","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1016\/j.bja.2020.05.046","article-title":"Association between mutated Mas-related G protein-coupled receptor-X2 and rocuronium-induced intraoperative anaphylaxis","volume":"125","author":"Suzuki","year":"2020","journal-title":"Br J Anaesth"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822011382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822011382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:36:04Z","timestamp":1761975364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822011382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2213219822011382"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.11.001","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Characteristics Associated With Reactions to Mrgprx2-Activating Drugs in an Electronic Health Record\u2013Linked Biobank","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}